Public versus Private Drug Insurance and Outcomes of Patients Requiring Biologic Therapies for Inflammatory Bowel Disease

Background. Antitumor necrosis factor (anti-TNF) therapy is a highly effective but costly treatment for inflammatory bowel disease (IBD). Methods. We conducted a retrospective cohort study of IBD patients who were prescribed anti-TNF therapy (2007–2014) in Ontario. We assessed if the insurance type...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Can J Gastroenterol Hepatol
Main Authors: Rumman, Amir, Candia, Roberto, Sam, Justina J., Croitoru, Kenneth, Silverberg, Mark S., Steinhart, A. Hillary, Nguyen, Geoffrey C.
Formato: Artigo
Idioma:Inglês
Publicado em: Hindawi Publishing Corporation 2017
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5292380/
https://ncbi.nlm.nih.gov/pubmed/28239601
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2017/7365937
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados